[go: up one dir, main page]

NO985576L - Konstruksjon og anvendelse av gener som koder for patogene epitoper for behandling av autoimmunsykdommer - Google Patents

Konstruksjon og anvendelse av gener som koder for patogene epitoper for behandling av autoimmunsykdommer

Info

Publication number
NO985576L
NO985576L NO985576A NO985576A NO985576L NO 985576 L NO985576 L NO 985576L NO 985576 A NO985576 A NO 985576A NO 985576 A NO985576 A NO 985576A NO 985576 L NO985576 L NO 985576L
Authority
NO
Norway
Prior art keywords
construction
treatment
autoimmune diseases
genes encoding
pathogenic epitopes
Prior art date
Application number
NO985576A
Other languages
English (en)
Other versions
NO985576D0 (no
Inventor
Leslie P Weiner
Minnie Mcmillan
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of NO985576D0 publication Critical patent/NO985576D0/no
Publication of NO985576L publication Critical patent/NO985576L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO985576A 1996-05-29 1998-11-27 Konstruksjon og anvendelse av gener som koder for patogene epitoper for behandling av autoimmunsykdommer NO985576L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/654,737 US6274136B1 (en) 1996-05-29 1996-05-29 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
PCT/US1997/010214 WO1997045144A1 (en) 1996-05-29 1997-05-29 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease

Publications (2)

Publication Number Publication Date
NO985576D0 NO985576D0 (no) 1998-11-27
NO985576L true NO985576L (no) 1999-01-19

Family

ID=24626060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985576A NO985576L (no) 1996-05-29 1998-11-27 Konstruksjon og anvendelse av gener som koder for patogene epitoper for behandling av autoimmunsykdommer

Country Status (7)

Country Link
US (3) US6274136B1 (no)
EP (1) EP1015034A4 (no)
AU (1) AU734633B2 (no)
CA (1) CA2256577A1 (no)
NO (1) NO985576L (no)
RU (1) RU2248807C2 (no)
WO (1) WO1997045144A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8323963B2 (en) * 1996-05-29 2012-12-04 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
US6274136B1 (en) * 1996-05-29 2001-08-14 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
US7030098B2 (en) 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
DE60023673T2 (de) * 1999-03-12 2006-07-20 The Board Of Trustees Of The Leland Stanford Junior University, Stanford Dna-impfung zur behandlung von autoimmunerkrankungen
US6884785B2 (en) 1999-06-17 2005-04-26 The Scripps Research Institute Compositions and methods for the treatment or prevention of autoimmune diabetes
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
EP1379130A2 (en) * 2001-02-27 2004-01-14 University Of Southern California Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
US7378089B2 (en) * 2001-10-02 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Gene therapy for the prevention of autoimmune disease
CN101670119A (zh) 2001-11-21 2010-03-17 利兰·斯坦福青年大学托管委员会 多核苷酸
US20040156826A1 (en) * 2002-09-27 2004-08-12 Fernando Dangond Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues
JP2009511014A (ja) * 2005-10-05 2009-03-19 ベイヒル セラピューティクス インコーポレーティッド 自己免疫疾患の処置のための組成物および方法
AU2007260779A1 (en) * 2006-06-13 2007-12-21 Bayhill Therapeutics, Inc. Polynucleotide therapy
WO2013152291A1 (en) * 2012-04-05 2013-10-10 University Of Southern California Cell therapy technology to deliver radio-protective peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716826A (en) * 1988-03-21 1998-02-10 Chiron Viagene, Inc. Recombinant retroviruses
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
IL105347A0 (en) * 1992-04-09 1993-08-18 Autoimmune Corp Multiple sclerosis t-cell receptor
WO1994011011A1 (en) * 1992-11-09 1994-05-26 Diacrin, Inc. Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs
JPH09501055A (ja) * 1993-07-30 1997-02-04 ユニバーシティ オブ メディシン アンド デンティストリー オブ ニュージャージー 初代リンパ球への効率的遺伝子転移
CA2250058A1 (en) * 1996-03-25 1997-10-02 Dennis Panicali Recombinant pox virus encoding myelin protein for therapy
US6274136B1 (en) * 1996-05-29 2001-08-14 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease

Also Published As

Publication number Publication date
US6274136B1 (en) 2001-08-14
CA2256577A1 (en) 1997-12-04
US20040071673A1 (en) 2004-04-15
EP1015034A1 (en) 2000-07-05
NO985576D0 (no) 1998-11-27
WO1997045144A1 (en) 1997-12-04
EP1015034A4 (en) 2004-12-01
AU734633B2 (en) 2001-06-21
AU3234297A (en) 1998-01-05
RU2248807C2 (ru) 2005-03-27
US20020141983A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
BR9611114A (pt) Celulases os genes codificando-as e os usos das mesmas
NO983266D0 (no) Distribuert Behandling
DE59406123D1 (de) Haarbehandlungsmittel
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
ID18679A (id) Penggunaan terapi lanjutan
NO985576L (no) Konstruksjon og anvendelse av gener som koder for patogene epitoper for behandling av autoimmunsykdommer
DE69732464D1 (de) Äusserliches gelförmiges Hautpflegemittel
IS5056A (is) Ný meðhöndlun á liðbólgu
FI965204A0 (fi) Bromelaiinin lääkekäyttö
DE69624037D1 (de) Tragbare Sauna
DE69732024D1 (de) Haarbehandlungsmittel
NO951825D0 (no) Vannbasert hårbehandlingspreparat og anvendelse av dette
DE69508135D1 (de) Ruhestuhl
NO983263L (no) Distribuert behandling
ID19542A (id) Pengobatan baru
EP1037669A4 (en) THERAPEUTIC USE OF LENTIVIRAL VECTORS
DE59708501D1 (de) Haarbehandlungsmittel
DE69634044D1 (de) Menschliches cyclin i und das dafuer kodierende gen
DE59607418D1 (de) Haarbehandlungsmittel
KR970016041U (ko) 의자의 등판 결착구
KR970048803U (ko) 놀이시설 자유 이용권으로 사용하는 핸드링의 개량구조
BR9604756A (pt) Banheira hospitalar
BR9605327A (pt) Microdispositivo eletroepidermico bionizador do ser humano
ZA974375B (en) Benzofuran carboxamides and their therapeutic use.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application